PET-CT FOR STAGING AND EARLY RESPONSE—RESULTS FROM THE RESPONSE ADAPTED THERAPY IN ADVANCED HODGKIN LYMPHOMA (RATHL) STUDY

018

  • Barrington, S. F.
  • O'Doherty, M. J.
  • Roberts, T. H.
  • Kirkwood, A.
  • Viney, Z. N.
  • Franceschetto, A.
  • Fulham, M. J.
  • Cucca, M.
  • Almquist, H.
  • Brun, E.
  • Hjorthaug, K.
  • Pike, L. C.
  • Sinclair, D. A.
  • Johnson, P. W.

  • 1PET Imaging Centre at St Thomas', Division of Imaging Sciences and Biomedical Engineering, King's College, London, UK;

    2Cancer Trials Centre, Cancer Research UK and UCL, London, UK;

    3Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK;

    4Department of Nuclear Medicine, University of Modena and Reggio Emilia, Modena, Italy;

    5Molecular Imaging (PET-CT), Royal Prince Alfred Hospital, Sydney, Australia;

    6Department of Oncology and Clinical Physiology, Lund University Hospital, Lund, Sweden;

    7Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark;

    8Cancer Research UK Centre, University of Southampton, Southampton, UK.

Hematological Oncology 31:p 101-102, June 2013.
Copyright © 2013 John Wiley & Sons, Inc.